Redsense releases BioStock CEO interview following Q3 2025 report

Halmstad, Sweden, November 19, 2025 – Redsense Medical AB (publ) (“Redsense'' or “the Company”) announces that a video interview with CEO Sebastien Bollue has been published by BioStock.

In the interview, Sebastien Bollue comments on the recently released Q3 2025 report, reflects on his tenure as CEO, and provides a short outlook.

The interview is available at the following link: https://biostock.se/2025/11/redsense-medical-vi-har-ett-valdigt-starkt-fokus-framat/

It is also accessible via the BioStock website: www.biostock.se